You're receiving this email because you're subscribed to Future Finance from Benzinga. To manage your subscription, click the link at the bottom of this email.

Happy Tuesday, Zingernation! Bitcoin miner Riot Platform will ‘Outperform’ say the analysts from Bernstein. Here’s their new price target.

Today, we look at what technical analysis is saying about Bitcoin, what is going on with MSTR stock and more.

MARKET SNAPSHOT

TOP STORY

What Does Technical Analysis Say About Bitcoin?

Uptober didn’t have the start we were looking for.

Bitcoin is back below $63,000 even though everyone and their mom promised we’d go up only.

So, what do the technical analysts have to say about that?

Read the full scoop here.

TOGETHER WITH INMED

InMed's INM-901 Oral Formulation Reaches Equivalent Brain Drug Levels As IP Injection

InMed Pharmaceuticals is hoping to have a significant impact on Alzheimer's treatment with INM-901, a medication that could improve lives. Current therapies typically require regular hospital visits for IV infusions. InMed’s new offering dispenses with the complicated IV model and comes in a convenient and simple oral formulation. Critically, INM-901 is a small molecule and crosses the blood-brain barrier effectively, the company says.

A recent seven-month-long, preclinical study was completed and showed significant improvements between those treated with INM-901 and a control group in:

• Cognitive function

• Memory

• Locomotion

• Behavior

INM-901 could provide hope for millions affected by Alzheimer's.

Don't miss out on this potential game-changer in neurodegenerative disease treatment!

QUICK N DIRTY

Robinhood is launching crypto transfers for its European customers. It also announced a 1% match on all crypto deposits in Europe - here’s why.

Riot Platforms got a new price target from Bernstein. The analysts maintained their Outperform rating - here’s their new target.

Bitcoin could go to $586,000 until 2028, according to an especially bullish trader. He cited several macro factors for his prediction - read here which ones.

FINTECH FOCUS

What's Going On With MicroStrategy Stock?

MicroStrategy is another casualty of this red Tuesday.

The stock is down together with Bitcoin as new instability in the Middle East is brewing.

But there are also good news, such as the latest release of MicroStrategy ONE, its fully cloud-native AI/BI platform.

What exactly does it do?

Read the full scoop here.

BEFORE YOU GO

Were you forwarded this email? Click here to subscribe.

And be sure to check out our other newsletters:

Ring The Bell: Created for market enthusiasts by market enthusiasts, this twice-daily newsletter delivers top stories, fast movers, and hot trade ideas straight to your inbox. Subscribe here.

Cannabis Daily: A must-read daily briefing for cannabis investors, operators, and enthusiasts. Join our list of industry veterans to jump start your morning. Subscribe here.

Real Estate Weekly: Where we highlight the movers and the losers, the upgrades and the downgrades, the top stories and opportunities in the trillion dollar REIT and real asset industry. Subscribe here.

Advisor: Tailor-made for Financial Advisors, this weekly newsletter has industry-specific insights, analysis, and news. Subscribe here.

Disclaimer: This communication from Benzinga is for informational purposes only. It is not intended to serve as a recommendation to buy, sell, or hold any security and is not an offer or sale of a security. Information contained within should not be perceived as a research report and is not intended to serve as the basis for any investment decision. Any third-party views reflected herein do not reflect the opinion of Benzinga. All investments involve risk and the past performance of a security does not guarantee future results or returns. There is always the potential for financial loss when investing in securities or other financial products. Investors should consider their investment objectives and risks before investing. Benzinga is reader-supported. When you buy through links on our site, we may earn an affiliate commission. Benzinga may receive monetary compensation from the issuer, or its agency, for publicizing the offering of the issuer’s securities. This content is for informational purposes only and is not intended to be investing advice. This is a paid ad. Please see 17b disclosure linked in the campaign page for more information.

Read the complete TradeZero contest details in the Contest Instructions.